Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 1;139(10):1053-1060.
doi: 10.1001/jamaophthalmol.2021.2617.

Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma

Affiliations

Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma

Jian-Yu E et al. JAMA Ophthalmol. .

Abstract

Importance: Gait dysfunction is common in older people with visual impairment and is a major cause of falls.

Objective: To compare 3-year longitudinal changes in gait measures across the spectrum of baseline visual field (VF) damage in glaucoma.

Design, setting, and participants: A post hoc analysis was designed on September 1, 2018, following a prospective cohort study, which enrolled older adults with glaucoma or suspected glaucoma from September 2013 to March 2015 and followed up for up to 3 years. Baseline VF damage was defined by integrated VF (IVF) sensitivity and categorized as normal/mild (IVF >28 dB), moderate (IVF, 23-28 dB), and severe (IVF, <23 dB). Each participant walked on an electronic walkway back and forth twice at normal pace each study year. Linear mixed-effects models evaluated longitudinal change in gait outcomes (1) stratified within each VF severity category and (2) across the range of IVF sensitivity. Analysis took place from October 2019 to October 2020.

Main outcomes and measures: Three-year changes in 7 gait assessments under usual-pace walking, including base support and its coefficient of variation, stride length and its coefficient of variation, stride velocity and its coefficient of variation, and cadence.

Results: Of 241 participants, the mean (SD) age was 70.8 (7.7) years, 116 (48.2%) were women, and 70 (29.0%) were African American. When comparing longitudinal gait changes over 3 years across the spectrum of IVF sensitivity, each 5-unit (dB) decrement was associated with more rapid declines in stride velocity (-0.05 z score unit/y; 95% CI, -0.09 to -0.01; P = .01) and cadence (-0.07 z score unit/y; 95% CI, -0.10 to -0.03; P < .001). When evaluating gait changes within each glaucoma severity group, shorter stride length was associated with persons with normal/mild (-0.06 z score unit/y; 95% CI, -0.10 to -0.03; P = .001), moderate (-0.08 z score unit/y; 95% CI, -0.12 to -0.04; P < .001), and severe VF damage (-0.16 z score unit/y; 95% CI, -0.24 to -0.07; P < .001), while stride velocity (-0.18 z score unit; 95% CI, -0.28 to -0.07; P = .002) and slower cadence (-0.15 z score unit; 95% CI, -0.25 to -0.04; P = .006) were associated with those with severe VF damage.

Conclusions and relevance: At worse levels of baseline VF damage, patients with glaucoma in this study demonstrated an exacerbated decline in walking speeds (ie, stride velocity and cadence), indicating that mobility speeds decrease faster over time in older adults with glaucoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Ms Mihailovic reported grants from the National Eye Institute during the conduct of the study. Dr Schrack reported grants from the National Institute on Aging during the conduct of the study. Dr Ramulu reported grants from the National Institutes of Health during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Stride Length, Velocity, and Cadency by Severity of Visual Field Damage Over 3 Years
Normal/mild (integrated visual field sensitivity >28 dB), moderate (integrated visual field, 23-28 dB), or severe (integrated visual field, <23 dB). There were 241 individuals (119 in normal/mild, 98 in moderate, and 24 in severe groups) for year 1, 212 (104 in normal/mild, 87 in moderate, and 21 in severe groups) for year 2, 191 (94 in normal/mild, 76 in moderate, and 21 in severe groups) for year 3, and 171 (84 in normal/mild, 70 in moderate, and 17 in severe groups) for year 4.

Comment in

References

    1. Fried LP, Bandeen-Roche K, Chaves PH, Johnson BA. Preclinical mobility disability predicts incident mobility disability in older women. J Gerontol A Biol Sci Med Sci. 2000;55(1):M43-M52. doi:10.1093/gerona/55.1.M43 - DOI - PubMed
    1. Mahlknecht P, Kiechl S, Bloem BR, et al. . Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study. PLoS One. 2013;8(7):e69627-e69627. doi:10.1371/journal.pone.0069627 - DOI - PMC - PubMed
    1. Bloem BR, Haan J, Lagaay AM, van Beek W, Wintzen AR, Roos RAC. Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol. 1992;5(2):78-84. doi:10.1177/002383099200500204 - DOI - PubMed
    1. Studenski S, Perera S, Patel K, et al. . Gait speed and survival in older adults. JAMA. 2011;305(1):50-58. doi:10.1001/jama.2010.1923 - DOI - PMC - PubMed
    1. Alam U, Riley DR, Jugdey RS, et al. . Diabetic neuropathy and gait: a review. Diabetes Ther. 2017;8(6):1253-1264. doi:10.1007/s13300-017-0295-y - DOI - PMC - PubMed

Publication types